Literature DB >> 3489956

In vitro enhanced thromboxane B2 release by polymorphonuclear leukocytes and macrophages after treatment with human recombinant interleukin 1.

P Conti, M G Cifone, E Alesse, M Reale, C Fieschi, C A Dinarello.   

Abstract

Macrophages (M phi) and polymorphonuclear leukocytes (PMNs) are cell types that interact with bacterial endotoxin and play key roles in mediating the inflammatory reaction. We examined the ability of rat peritoneal macrophages and human PMNs to synthesize thromboxane A2 (detected as TxB2) in response to human recombinant interleukin 1 (hrIL1). TxB2 levels were measured by radioimmunoassay in the cell-free supernatant of cell suspensions after 1 hr incubation at 37 degrees C. TxB2 release by both PMNs and M phis was increased in a dose-dependent manner by hrIL1.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3489956     DOI: 10.1016/0090-6980(86)90151-6

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  9 in total

1.  Seventh European Rheumatology Research Workshop. Glasgow, Scotland, March 6-7, 1987. Abstracts.

Authors: 
Journal:  Clin Rheumatol       Date:  1987-03       Impact factor: 2.980

Review 2.  Interleukin-1.

Authors:  C A Dinarello
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

3.  Recombinant interleukin-1 beta interacts with high-affinity receptors to activate neutrophil leukotriene B4 synthesis.

Authors:  L Borish; R Rosenbaum; B McDonald; L J Rosenwasser
Journal:  Inflammation       Date:  1990-04       Impact factor: 4.092

4.  Infra-red laser irradiation enhances interleukin-1 receptor antagonist, increases 3H-thymidine incorporation and the release of [3H]arachidonic acid in human monocytes.

Authors:  M Reale; C Orso; M L Castellani; R C Barbacane; F C Placido; E Porreca; C Di Febbo; I Cataldo; D Vacalis; G Anogianakis; A Trakatellis; P Conti
Journal:  Mol Cell Biochem       Date:  1997-04       Impact factor: 3.396

5.  Eicosanoid regulation of acute intestinal vascular permeability induced by intravenous peptidoglycan-polysaccharide polymers.

Authors:  C J Woolverton; J J White; R B Sartor
Journal:  Agents Actions       Date:  1989-03

6.  Excretion of metabolites of prostacyclin and thromboxane by rats with nephrotoxic nephritis: effects of interleukin-1.

Authors:  P S Ward; R W Fuller; J M Ritter; S J Cashman; A J Rees; C T Dollery
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

7.  Interleukin-1 receptor antagonist inhibits calcium accumulation in in vivo chronic granuloma induced by potassium permanganate.

Authors:  P Conti; M Reale; M R Panara; S Fridas; F C Placido; R C Barbacane
Journal:  Calcif Tissue Int       Date:  1993-04       Impact factor: 4.333

8.  Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.

Authors:  S Okusawa; J A Gelfand; T Ikejima; R J Connolly; C A Dinarello
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

9.  The down-regulation of IL-6-stimulated fibrinogen steady state mRNA and protein levels by human recombinant IL-1 is not PGE2-dependent: effects of IL-1 receptor antagonist (IL-1RA).

Authors:  P Conti; L Bartle; R C Barbacane; M Reale; J D Sipe
Journal:  Mol Cell Biochem       Date:  1995-01-26       Impact factor: 3.396

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.